# VERRA MOBILITY Corp: financial statements, quarterly

VRRM · Nasdaq · CIK 1682745 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vrrm.md) · [Financials](/companies/vrrm/financials.md) · [Filings](/companies/vrrm/filings.md) · [Insiders](/companies/vrrm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vrrm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [211 d](/filings/0001193125-26-067293.md) | [210](/filings/0000950170-25-065808.md) | [222](/filings/0000950170-25-104192.md) | [226](/filings/0001193125-25-256492.md) | [222 d](/filings/0001193125-26-067293.md) | [223](/filings/0001193125-26-209227.md) | [236](/filings/0001193125-26-335490.md) | [262](/filings/0001628280-26-068455.md) | [258 d](/filings/0001193125-26-067293.md) | [224](/filings/0001193125-26-209227.md) | [264](/filings/0001193125-26-335490.md) | [259](/filings/0001628280-26-068455.md) |
| Selling, general and administrative | $m | [73.1 d](/filings/0001193125-26-067293.md) | [48.2](/filings/0000950170-25-065808.md) | [46.3](/filings/0000950170-25-104192.md) | [47.9](/filings/0001193125-25-256492.md) | [52.6 d](/filings/0001193125-26-067293.md) | [51.5](/filings/0001193125-26-209227.md) | [48.5](/filings/0001193125-26-335490.md) | [47.8](/filings/0001628280-26-068455.md) | [67.6 d](/filings/0001193125-26-067293.md) | [40.9](/filings/0001193125-26-209227.md) | [44.0](/filings/0001193125-26-335490.md) | [43.4](/filings/0001628280-26-068455.md) |
| Operating income | $m | [23.3 d](/filings/0001193125-26-067293.md) | [54.4](/filings/0000950170-25-065808.md) | [61.2](/filings/0000950170-25-104192.md) | [63.9](/filings/0001193125-25-256492.md) | [(43.4) d](/filings/0001193125-26-067293.md) | [57.4](/filings/0001193125-26-209227.md) | [63.2](/filings/0001193125-26-335490.md) | [74.8](/filings/0001628280-26-068455.md) | [43.0 d](/filings/0001193125-26-067293.md) | [51.8](/filings/0001193125-26-209227.md) | [(32.8)](/filings/0001193125-26-335490.md) | [65.6](/filings/0001628280-26-068455.md) |
| Interest expense | $m | [20.9 d](/filings/0000950170-24-023271.md) | [19.6](/filings/0000950170-24-052307.md) | [18.8](/filings/0000950170-24-094172.md) | [18.7](/filings/0000950170-24-119627.md) | [16.7 d](/filings/0001193125-26-067293.md) | [16.6](/filings/0001193125-26-209227.md) | [16.6](/filings/0001193125-26-335490.md) | [16.4](/filings/0001628280-26-068455.md) | [15.0 d](/filings/0001193125-26-067293.md) | [15.4](/filings/0001193125-26-209227.md) | [15.5](/filings/0001193125-26-335490.md) | [15.0](/filings/0001628280-26-068455.md) |
| Income tax | $m | [(1.9) d](/filings/0001193125-26-067293.md) | [9.8](/filings/0000950170-25-065808.md) | [13.4](/filings/0000950170-25-104192.md) | [13.8](/filings/0001193125-25-256492.md) | [10.7 d](/filings/0001193125-26-067293.md) | [12.5](/filings/0001193125-26-209227.md) | [14.0](/filings/0001193125-26-335490.md) | [17.8](/filings/0001628280-26-068455.md) | [14.0 d](/filings/0001193125-26-067293.md) | [13.7](/filings/0001193125-26-209227.md) | [6.0](/filings/0001193125-26-335490.md) | [14.9](/filings/0001628280-26-068455.md) |
| Net income | $m | [3.0 d](/filings/0001193125-26-067293.md) | [29.1](/filings/0001193125-25-256492.md) | [34.2](/filings/0001193125-25-256492.md) | [34.7](/filings/0001193125-25-256492.md) | [(66.7) d](/filings/0001193125-26-067293.md) | [32.3](/filings/0001628280-26-068455.md) | [38.6](/filings/0001628280-26-068455.md) | [46.8](/filings/0001628280-26-068455.md) | [18.9 d](/filings/0001193125-26-067293.md) | [26.7](/filings/0001628280-26-068455.md) | [(48.2)](/filings/0001628280-26-068455.md) | [40.4](/filings/0001628280-26-068455.md) |
| Diluted EPS | $ per share | not reported | [0.17](/filings/0000950170-25-065808.md) | [0.20](/filings/0000950170-25-104192.md) | [0.21](/filings/0001193125-25-256492.md) | not reported | [0.20](/filings/0001193125-26-209227.md) | [0.24](/filings/0001193125-26-335490.md) | [0.29](/filings/0001628280-26-068455.md) | not reported | [0.17](/filings/0001193125-26-209227.md) | [(0.32)](/filings/0001193125-26-335490.md) | [0.27](/filings/0001628280-26-068455.md) |
| Basic EPS | $ per share | not reported | [0.18](/filings/0000950170-25-065808.md) | [0.21](/filings/0000950170-25-104192.md) | [0.21](/filings/0001193125-25-256492.md) | not reported | [0.20](/filings/0001193125-26-209227.md) | [0.24](/filings/0001193125-26-335490.md) | [0.29](/filings/0001628280-26-068455.md) | not reported | [0.18](/filings/0001193125-26-209227.md) | [(0.32)](/filings/0001193125-26-335490.md) | [0.27](/filings/0001628280-26-068455.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [136](/filings/0001193125-26-067293.md) | [150](/filings/0000950170-25-065808.md) | [122](/filings/0000950170-25-104192.md) | [206](/filings/0001193125-25-256492.md) | [77.6](/filings/0001193125-26-067293.md) | [108](/filings/0001193125-26-209227.md) | [148](/filings/0001193125-26-335490.md) | [196](/filings/0001628280-26-068455.md) | [65.3](/filings/0001628280-26-068455.md) | [46.9](/filings/0001193125-26-209227.md) | [49.6](/filings/0001193125-26-335490.md) | [137](/filings/0001628280-26-068455.md) |
| Current assets | $m | [440](/filings/0000950170-25-029180.md) | [439](/filings/0000950170-24-052307.md) | [450](/filings/0000950170-24-094172.md) | [529](/filings/0000950170-24-119627.md) | [394](/filings/0001193125-26-067293.md) | [426](/filings/0000950170-25-065808.md) | [475](/filings/0000950170-25-104192.md) | [558](/filings/0001193125-25-256492.md) | [441](/filings/0001628280-26-068455.md) | [439](/filings/0001193125-26-209227.md) | [491](/filings/0001193125-26-335490.md) | [528](/filings/0001628280-26-068455.md) |
| Total assets | $m | [1,790](/filings/0000950170-25-029180.md) | [1,770](/filings/0000950170-24-052307.md) | [1,773](/filings/0000950170-24-094172.md) | [1,851](/filings/0000950170-24-119627.md) | [1,614](/filings/0001193125-26-067293.md) | [1,643](/filings/0000950170-25-065808.md) | [1,695](/filings/0000950170-25-104192.md) | [1,778](/filings/0001193125-25-256492.md) | [1,646](/filings/0001628280-26-068455.md) | [1,656](/filings/0001193125-26-209227.md) | [1,616](/filings/0001193125-26-335490.md) | [1,672](/filings/0001628280-26-068455.md) |
| Current liabilities | $m | [215](/filings/0000950170-25-029180.md) | [159](/filings/0000950170-24-052307.md) | [175](/filings/0000950170-24-094172.md) | [202](/filings/0000950170-24-119627.md) | [200](/filings/0001193125-26-067293.md) | [195](/filings/0000950170-25-065808.md) | [208](/filings/0000950170-25-104192.md) | [228](/filings/0001193125-25-256492.md) | [210](/filings/0001628280-26-068455.md) | [232](/filings/0001193125-26-209227.md) | [238](/filings/0001193125-26-335490.md) | [257](/filings/0001628280-26-068455.md) |
| Total liabilities | $m | [1,369](/filings/0000950170-25-029180.md) | [1,321](/filings/0000950170-24-052307.md) | [1,334](/filings/0000950170-24-094172.md) | [1,364](/filings/0000950170-24-119627.md) | [1,349](/filings/0001193125-26-067293.md) | [1,344](/filings/0000950170-25-065808.md) | [1,343](/filings/0000950170-25-104192.md) | [1,375](/filings/0001193125-25-256492.md) | [1,353](/filings/0001628280-26-068455.md) | [1,384](/filings/0001193125-26-209227.md) | [1,393](/filings/0001193125-26-335490.md) | [1,408](/filings/0001628280-26-068455.md) |
| Long-term debt | $m | [1,029](/filings/0000950170-25-029180.md) | [1,038](/filings/0000950170-24-052307.md) | [1,036](/filings/0000950170-24-094172.md) | [1,037](/filings/0000950170-24-119627.md) | [1,034](/filings/0001193125-26-067293.md) | [1,033](/filings/0000950170-25-065808.md) | [1,031](/filings/0000950170-25-104192.md) | [1,030](/filings/0001193125-25-256492.md) | [1,021](/filings/0001628280-26-068455.md) | [1,021](/filings/0001193125-26-209227.md) | [1,025](/filings/0001193125-26-335490.md) | [1,023](/filings/0001628280-26-068455.md) |
| Current portion of debt | $m | [9.0](/filings/0000950170-25-029180.md) | [0.0](/filings/0000950170-24-052307.md) | [0.0](/filings/0000950170-24-094172.md) | [0.0](/filings/0000950170-24-119627.md) | [0.0](/filings/0001193125-26-067293.md) | not reported | not reported | not reported | [6.9](/filings/0001628280-26-068455.md) | [34.1](/filings/0001193125-26-209227.md) | [10.0](/filings/0001193125-26-335490.md) | [9.5](/filings/0001628280-26-068455.md) |
| Shareholders' equity | $m | [421](/filings/0001193125-26-067293.md) | [449](/filings/0001193125-25-256492.md) | [439](/filings/0001193125-25-256492.md) | [487](/filings/0001193125-25-256492.md) | [265](/filings/0001628280-26-068455.md) | [300](/filings/0001628280-26-068455.md) | [352](/filings/0001628280-26-068455.md) | [403](/filings/0001628280-26-068455.md) | [293](/filings/0001628280-26-068455.md) | [272](/filings/0001628280-26-068455.md) | [224](/filings/0001628280-26-068455.md) | [265](/filings/0001628280-26-068455.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [35.7 d](/filings/0001193125-26-067293.md) | [34.3](/filings/0000950170-25-065808.md) | [40.0 d](/filings/0000950170-25-104192.md) | [109 d](/filings/0001193125-25-256492.md) | [40.5 d](/filings/0001193125-26-067293.md) | [63.0](/filings/0001193125-26-209227.md) | [75.1 d](/filings/0001193125-26-335490.md) | [77.7 d](/filings/0001628280-26-068455.md) | [40.0 d](/filings/0001193125-26-067293.md) | [40.8](/filings/0001193125-26-209227.md) | [56.4 d](/filings/0001193125-26-335490.md) | [115 d](/filings/0001628280-26-068455.md) |
| Capital expenditure | $m | [16.5 d](/filings/0001193125-26-067293.md) | [14.3](/filings/0000950170-25-065808.md) | [14.1 d](/filings/0000950170-25-104192.md) | [23.7 d](/filings/0001193125-25-256492.md) | [18.8 d](/filings/0001193125-26-067293.md) | [21.2](/filings/0001193125-26-209227.md) | [34.9 d](/filings/0001193125-26-335490.md) | [28.8 d](/filings/0001628280-26-068455.md) | [34.2 d](/filings/0001193125-26-067293.md) | [31.2](/filings/0001193125-26-209227.md) | [23.8 d](/filings/0001193125-26-335490.md) | [25.1 d](/filings/0001628280-26-068455.md) |
| Share repurchases | $m | [0.0 d](/filings/0001193125-26-067293.md) | not reported | not reported | [0.0 d](/filings/0001193125-25-256492.md) | [148 d](/filings/0001193125-26-067293.md) | [0.0](/filings/0001193125-26-209227.md) | [0.0 d](/filings/0001193125-26-335490.md) | [0.0 d](/filings/0001628280-26-068455.md) | [133 d](/filings/0001193125-26-067293.md) | [50.2](/filings/0001193125-26-209227.md) | [1.3 d](/filings/0001193125-26-335490.md) | [0.0 d](/filings/0001628280-26-068455.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [153](/filings/0000950170-24-052307.md) | [153](/filings/0000950170-24-094172.md) | [169](/filings/0000950170-24-119627.md) | [169](/filings/0000950170-25-065808.md) | [169](/filings/0000950170-25-104192.md) | [168](/filings/0001193125-25-256492.md) | [162](/filings/0001193125-26-209227.md) | [162](/filings/0001193125-26-335490.md) | [162](/filings/0001628280-26-068455.md) | [154](/filings/0001193125-26-209227.md) | [152](/filings/0001193125-26-335490.md) | [152](/filings/0001628280-26-068455.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 152,009,343 at 2026-10-27, from the cover of the [10-Q filed 2026-10-30](/filings/0001628280-26-068455.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 03:18 ET. No prices; not investment advice.